TSE:VRX - Valeant Pharmaceuticals Intl Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Valeant Pharmaceuticals Intl Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range N/A52-Week Range N/AVolume557,537 shsAverage Volume1.38 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInsider TradesHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. Read More… Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:VRX Previous Symbol CUSIPN/A CIKN/A Webhttp://www.valeant.com/ Phone+1-514-7446792Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive VRX News and Ratings via Email Sign-up to receive the latest news and ratings for VRX and its competitors with MarketBeat's FREE daily newsletter. TSX:VRX Rates by TradingView Valeant Pharmaceuticals Intl (TSE:VRX) Frequently Asked Questions What is Valeant Pharmaceuticals Intl's stock symbol? Valeant Pharmaceuticals Intl trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VRX." Has Valeant Pharmaceuticals Intl been receiving favorable news coverage? Media coverage about VRX stock has been trending extremely negative recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Valeant Pharmaceuticals Intl earned a media sentiment score of -4.5 on InfoTrie's scale. They also gave headlines about the specialty pharmaceutical company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Valeant Pharmaceuticals Intl. Who are some of Valeant Pharmaceuticals Intl's key competitors? Some companies that are related to Valeant Pharmaceuticals Intl include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). What other stocks do shareholders of Valeant Pharmaceuticals Intl own? Based on aggregate information from My MarketBeat watchlists, some companies that other Valeant Pharmaceuticals Intl investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Toronto-Dominion Bank (TD). Who are Valeant Pharmaceuticals Intl's key executives? Valeant Pharmaceuticals Intl's management team includes the folowing people: Mr. Joseph C. Papa, CEO & Chairman (Age 63)Mr. Paul S. Herendeen, Exec. VP & CFO (Age 62)Ms. Christina M. Ackermann, Exec. VP & Gen. Counsel (Age 53)Mr. Thomas J. Appio, Exec. VP & Group Chairman of International (Age 56)Mr. William D. Humphries, Exec. VP & Group Chairman of Dermatology (Age 52) How do I buy shares of Valeant Pharmaceuticals Intl? Shares of VRX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Valeant Pharmaceuticals Intl's official website? The official website for Valeant Pharmaceuticals Intl is http://www.valeant.com/. How can I contact Valeant Pharmaceuticals Intl? Valeant Pharmaceuticals Intl's mailing address is 2150 Saint-Elzear Blvd W, LAVAL, QC H7L 4A8, Canada. The specialty pharmaceutical company can be reached via phone at +1-514-7446792. MarketBeat Community Rating for Valeant Pharmaceuticals Intl (TSE VRX)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 443 (Vote Outperform)Underperform Votes: 474 (Vote Underperform)Total Votes: 917MarketBeat's community ratings are surveys of what our community members think about Valeant Pharmaceuticals Intl and other stocks. Vote "Outperform" if you believe VRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/26/2020 by MarketBeat.com StaffFeatured Article: Why are analyst ratings important in trading stocks?
